Agilent Q3 revenue rises 8.1% to $1.88B; net income up 7.7% to $362.0M

Filed September 1, 2026 · Period ending July 31, 2026 · Compared to 10-Q Aug 29, 2025 · ~1 min read

Key Changes

• high

  Issued $600 million of 4.90% senior notes due 2032, lifting long-term debt to $3.65 billion.

  Notes: 2032 Senior Notes verify on EDGAR →
• high

  Gross margin expanded 4 percentage points to 55.5% in the quarter, helped by tariff refunds and favorable mix.

  MD&A: Gross margin verify on EDGAR →
• medium

  Raised full-year capital expenditure guidance to $450 million for advanced therapeutics capacity.

  MD&A: Capital expenditures verify on EDGAR →